Summit Shoji Inc.

Summit Shoji Inc., a Japan-based for-profit medical equipment and reagent supplier operating as a prime contractor, sells specialized in vitro diagnostic systems, hematology analyzers, blood typing equipment, laboratory reagents, and related medical consumables to the U.S. Department of Defense in the Pacific theater. The vendor competes exclusively in unrestricted, full-and-open federal procurements with no set-aside participation; all 498 awards in the source carry no set-aside designation.

Summit Shoji is headquartered in Makiminato, Urasoe, Okinawa, Japan, and operates as an international for-profit organization registered with SAM.gov since January 2006. The company supplies concrete diagnostic products: VITROS analyzers and reagents from Ortho Clinical Diagnostics, Micro Typing Systems (MTS) for blood banking and transfusion medicine, leukocyte reagents for immunological testing, hematology analyzers, SARS-CoV-2 test kits, and related laboratory consumables. Representative prime work includes a $4.62 million Indefinite Delivery Contract from DLA Pacific Region (awarded December 29, 2024, through December 28, 2027) for medical diagnostic equipment and reagents supporting U.S. Naval Hospital Okinawa, with ten documented delivery orders issued between March and December 2025 ranging from $40,287 to $124,768; a $350,000 single-award Blanket Purchase Agreement from the 18th Medical Group for hematology reagents (awarded February 4, 2026, through March 31, 2028); and a $6.2 million Indefinite Delivery Contract from DLA Troop Support Pacific (awarded December 9, 2021, through December 28, 2024) that generated 46 documented task orders for VITROS systems, micro typing equipment, and reagents.

Customer concentration is heavily weighted toward DLA Troop Support Pacific. The top three funding agencies account for 99% of recent awards: DLA Troop Support Pacific (375 awards, $37.8 million combined potential value), the Department of the Navy Bureau of Medicine and Surgery (106 awards, $15.6 million), and the Department of the Air Force Pacific Air Forces (9 awards, $1.9 million). The rankings align closely—DLA dominates both volume and dollars—but the Navy's concentration reflects numerous smaller delivery orders against multiple IDCs rather than one large vehicle.

Summit Shoji holds six active Indefinite Delivery Contracts as the vehicle infrastructure for task order placement. The largest vehicle by ceiling is the $6.2 million DLA Troop Support Pacific IDC (SPE8EQ22D0002, awarded December 9, 2021, extended through December 28, 2024), which generated 46 task orders. A newer $4.62 million DLA Pacific Region IDC (SPE8EQ25D0004, awarded December 29, 2024, through December 28, 2027) has already issued 10 delivery orders. Smaller vehicles include a $448,258 IDC (June 15, 2024, through June 14, 2028), a $249,290 IDC (December 15, 2023, through December 15, 2025), and a $47,780 IDC (November 10, 2025, through November 9, 2028). Summit Shoji also holds a $350,000 single-award Blanket Purchase Agreement with Pacific Air Forces (18th Medical Group) for hematology reagents through March 31, 2028, and a $240,000 BPA with the Department of the Air Force (through October 2025, superseded by the February 2026 $350,000 renewal). All vehicles are firm fixed-price, unrestricted competition.

Activity has remained steady over recent years—59 awards in 2022, 60 in 2023, 49 in 2024, declining to 27 in 2025 and 7 through April 2026. This contraction reflects the end-of-life cycle for certain older IDC vehicles (the $733,003 IDC completed September 15, 2022; the $6.2 million DLA Troop Support vehicle terminates December 28, 2024). Within the next twenty-four months, one award (the $99,074 hematology rental-and-maintenance purchase order from Pacific Air Forces) reaches ultimate completion, exposing minimal recompete risk in near-term dollars.

Summit Shoji operates 100% as a prime contractor across all 498 awards; the source documents no subcontract activity or sub-award relationships. The vendor sources its products directly from original equipment manufacturers (notably Ortho Clinical Diagnostics for VITROS systems) and functions as a distributor and supply-chain partner for DLA and military medical treatment facilities, rather than as a systems integrator or engineering firm. The company's capability portfolio aligns tightly with NAICS categories 424210 (Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers, 292 awards) and 424450 (Drugs and Druggists' Sundries Merchant Wholesalers, 88 awards), and PSC codes 6550 (Medical and Surgical Instruments, Equipment, and Supplies, 215 awards) and 6520 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets, 93 awards). All work is performed in Japan, with deliveries to USNH Okinawa, U.S. Naval Hospital Camp Foster, the 18th Medical Group Clinic Laboratory, and other military medical treatment facilities across the Pacific theater.